Aptose Biosciences Inc.
1 known investors
Aptose Biosciences is a clinical-stage biotechnology company developing small molecule cancer therapeutics, focused on precision oncology with an initial emphasis on hematology. Its pipeline is designed for single-agent efficacy and to improve the effectiveness of other anti-cancer treatments without overlapping toxicities.
Investors · 1
Frequently asked questions
- What does Aptose Biosciences Inc. do?
- Aptose Biosciences is a clinical-stage biotechnology company developing small molecule cancer therapeutics, focused on precision oncology with an initial emphasis on hematology. Its pipeline is designed for single-agent efficacy and to improve the effectiveness of other anti-cancer treatments without overlapping toxicities.
- Who are Aptose Biosciences Inc.'s investors?
- Aptose Biosciences Inc.'s investors include Venture Ontario.